Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Care Bare Rx vs Wisp

Care Bare Rx
Graded #43

Lower grade

vs+0.29999999999999716
Wisp
Graded #57

Higher grade

The verdict

Wisp takes it — 75.3/100 to 75/100, but only just.

Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month. Care Bare Rx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWisp +16
68
84
Dose & formulationCare Bare Rx +6
94
88
Clinical oversightWisp +8
74
82
Labs & monitoringCare Bare Rx +9
62
53
FulfillmentCare Bare Rx +12
78
66
Contract termsCare Bare Rx +17
72
55
Care Bare Rx · left barWisp · right bar

The numbers

MetricCare Bare RxWisp
WeighScore75/10075.3/100
GradeCC
Scorecard rank#43#57
SemaglutideFrom $199/mo (shared weight-loss price)$225/mo (compounded oral)
TirzepatideFrom $199/mo (shared weight-loss price)$99/mo (starting dose, brand-name)
CoverageMulti-stateCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
Care Bare Rx

Graded #43 · C

Strengths

  • Oral tirzepatide as well as injectable — rare on this board
  • Brand Ozempic (from $705/mo) and oral Rybelsus beside the compounded line
  • LegitScript certified and HIPAA compliant
  • One platform if you also want hair, TRT, sexual health or NAD+

Where it loses points

  • The advertised "from $199/mo" is one figure shared across all weight-loss treatments — neither molecule priced separately
  • Per-dose pricing is quiz-gated, so a titrated cost cannot be modelled beforehand
  • No named clinicians, founding year or parent company disclosed
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
Wisp

Graded #57 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • Sublingual compounded semaglutide hasn't been tested in humans, per Wisp's own page — only the injectables have FDA efficacy data
  • Pharmacy partners not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard